Fractyl Health Inc (GUTS) SEC 13F Holdings (Q2 2026) — Net Institutional Activity: -$8.9K

GUTS ranks #5197 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

76 institutions disclose a position in GUTS, but none treat it as a major bet — even M28 Capital Management LP, its most concentrated holder, allocates just 3.1% of its own portfolio to it.

BNP Paribas Financial Markets has added to its GUTS position for two straight quarters, increasing it by $423.4 to reach $441.0 today.

683 Capital Management, LLC has trimmed its GUTS position for two straight quarters, cutting it by $12.7M while still holding $601.1K.

GUTS reported a net loss of $141.0M in its latest fiscal year.

• Not yet profitable — net loss of $141.0M in the latest fiscal year
• Revenue declined 100.0% year over year
• Net income declined year over year, from -$68.7M to -$141.0M
• Operating cash flow was negative, using $90.3M in cash
• Current ratio of 4.78x — enough short-term assets to cover short-term liabilities
• Liabilities run 11.84x equity — a highly leveraged balance sheet worth noting